Clin2
NCT07255859Possibly a fitRecruiting

Home monitoring for wet AMD using a webcam

Maculopathy

Part of Eyes & vision clinical trials.

This study tests a home monitoring system using a webcam to check for signs of wet AMD returning. It may help you manage your condition between doctor visits and catch problems early.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
50 years to 99 years
Study type
Interventional

Who can take part

  • You are between 50 and 99 years old.
  • You are currently being treated for wet age-related macular degeneration (wet AMD).
  • You do not have any signs of active AMD (like new fluid or bleeding in the eye) at the start of the study.
  • You can understand spoken instructions in English, Chinese, or Malay.
  • You can turn on a computer and connect a webcam by yourself or with help from a family member.
  • You have not had eye surgery in the last 3 months or a vitrectomy in the last 12 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07338513Enrolling by invitation
Home eye-tracking tool for wet AMD monitoring

This study tests a web-based eye-tracking tool to monitor vision impairment in people with wet age-related macular degeneration (AMD). You would use your computer at home, which could help reduce the need for frequent clinic visits.

Singapore
NCT07653269Recruiting
Tracking eye changes to predict AMD progression

This study uses eye imaging and other tests to predict if early age-related macular degeneration (AMD) will progress to a more advanced stage. It aims to help doctors identify who might need closer monitoring in the future.

Singapore
NCT07249216Recruiting
Studying eye fluid to improve treatment for wet age-related macular degeneration

This study looks at whether certain proteins or molecules in the jelly-like fluid inside the eye can predict why some people with wet age-related macular degeneration do not respond well to standard anti-VEGF injections. By studying these signals, researchers hope to improve future treatment and better tailor care to individual patients.

Singapore
NCT07340372Not yet recruiting
Using a home app for wet age-related macular degeneration

This study tests whether using a smartphone app to monitor your vision at home can help manage wet age-related macular degeneration (AMD) while you continue your usual treatment. The app may help you and your doctor spot changes early, so you can adjust treatment sooner.

Coimbra
NCT07446582Recruiting
AI camera test for wet AMD detection

This study tests a new AI-powered camera that takes special pictures of the back of the eye to find signs of wet age-related macular degeneration (AMD) more easily. It compares images from people with wet AMD and healthy volunteers to see if the AI can spot the disease early.

Woodbridge, New Jersey
NCT07084883Recruiting
AI system for early AMD detection

This trial tests an AI system designed to catch early signs of late age-related macular degeneration (AMD) before it's diagnosed. It's for people who haven't yet been diagnosed with AMD or treated for retinal disease.

Richmond Hill, New York

Hear when a new Maculopathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.